Sign Up
Stories
Adial Pharmaceuticals Raises $3.5 Million
Share
Adial Pharmaceuticals Boosts AD04 Develo...
Adial Pharmaceuticals Raises $3.5M for D...
Adial Pharmaceuticals Raises Funds for A...
ADMA Biologics CFO Transition Announceme...
ADMA Biologics CFO Transition Revealed
ADOCIA Files 2023 Registration Document
Overview
API
Adial Pharmaceuticals has announced the exercise of warrants, generating $3.5 million in gross proceeds, to support general corporate activities and clinical development of AD04 for Alcohol Use Disorder treatment.
Ask a question
How will the proceeds impact the development of AD04 and its availability for patients?
In what ways might this fundraising affect the competitiveness of Adial Pharmaceuticals in the biopharmaceutical industry?
What regulatory challenges might Adial Pharmaceuticals face in advancing AD04 for Alcohol Use Disorder treatment?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage
finan
globe